Endocrine Society Opposes Taxing Graduate Tuition Waivers

Tax reform legislation (H.R. 1) approved by the U.S. House of Representatives will increase tax liability for thousands of graduate students who serve as teaching or research assistants.

Under the House-passed legislation, tuition waivers granted to graduate students would be considered taxable income. More than half (55%) of all master’s and PhD candidates who serve as teaching or research assistants have adjusted gross incomes of $20,000 or less. The increased tax burden would present a significant financial challenge to current students and may discourage the future pipeline of scientific researchers.

The Senate tax bill (S. 1) does not include the tax on graduate student tuition waivers. This week, as the House and Senate negotiate final language, Congress needs to hear from graduate students and others in the research community to ensure that the House provision on graduate student tuition is not included in the final tax bill.

The Endocrine Society strongly opposes this effort to treat graduate tuition waivers as taxable income.  Please join our campaign to oppose the taxing of the graduate tuition waiver. Click the “Take Action” button below to email your Senators and Representative TODAY and enter your name and address. You do not need to enter email and member ID.  Our software will generate a letter, but you can personalize it to describe how the proposed tax on graduate student tuition waivers would affect you or your institution.  Please also share this alert with graduate students and other faculty members.  Taking action will only take a minute of your time, but will make a difference.


You may also like

  • NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

    On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1…

  • Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

    As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain. A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and…

Find more in